CHC Saint Joseph

Liège 4000

0 studies enrolling now · 5 studies all time

What they study most

Atrial Fibrillation, BRAF V600E-mutant Metastatic Colorectal Cancer, Back Injuries, Crohn´s Disease, Fractures, Compression, Recurrent or Metastatic, Platinum-refractory Cervical Cancer, Spinal Fractures, Squamous Cell Carcinoma (SCC), Stroke

Studies at this site

• Study of Cemiplimab in Adults With Cervical Cancer — Completed
• Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed
• Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation — Completed
• The Kiva® System as a Vertebral Augmentation Treatment — Completed
• A Study With Pentasa in Patients With Active Crohn's Disease — Stopped early